High materiality8/10
Jefferies Starts Latigo Biotherapeutics (LTGO) at Buy
Why it may matterVerify against the original reporting
very_bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Jefferies started LTGO at Buy with a $50 target; posted price $22.02; Analyst Akash Tewari.
- LTGO Buy; PT $50; price $22.02; Jefferies
Key facts
- 01
Target: $50
- 02
Posted price: $22.02
- 03
Analyst firm: Jefferies
- 04
Analyst: Akash Tewari
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.